Field-Friendly Test for Monitoring Multiple Immune Response Markers during Onset and Treatment of Exacerbated Immunity in Leprosy

Clin Vaccine Immunol. 2016 Jun 6;23(6):515-519. doi: 10.1128/CVI.00033-16. Print 2016 Jun.

Abstract

Acute inflammatory reactions represent the major cause of irreversible neuropathy in leprosy. These tissue-destroying episodes have considerable overlap with acute immunological complications (flares) in several chronic (autoimmune) diseases that similarly warrant early detection. However, the lack of diagnostic tests impedes early diagnosis of these reactions. Here, we evaluated a user-friendly multiplex lateral flow assay for the simultaneous detection of IP-10 and anti-phenolic glycolipid I antibodies for longitudinally monitoring early onset and treatment of leprosy reactions.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Bacterial / blood*
  • Antigens, Bacterial / immunology*
  • Biomarkers / blood
  • Chemokine CXCL10 / blood*
  • Chemokine CXCL10 / immunology
  • Early Diagnosis
  • Enzyme-Linked Immunosorbent Assay*
  • Glycolipids / immunology*
  • Humans
  • Leprosy / complications
  • Leprosy / immunology*
  • Leprosy / therapy
  • Monitoring, Immunologic / methods*
  • Mycobacterium leprae / immunology
  • Point-of-Care Systems*

Substances

  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Biomarkers
  • CXCL10 protein, human
  • Chemokine CXCL10
  • Glycolipids
  • phenolic glycolipid I, Mycobacterium leprae